| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |